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ABSTRACT We have constructed three different fusion
genes containing the herpes simplex virus thymidine kinase
(HSV tk) and the bacterial neomycin phosphotransferase (neo)
genes. All three fusion genes utilize the HSV tk promoter but
differ at thejunction of their components. We have determined
if the fusion genes are bifunctional by introducing them into
mammalian cells and testing for function of the individual
components. One of the fusion genes, TNFUS 69, produced a
bicistronic message and a fusion protein that has TK and NEO
protein functions. This and other fusion genes of a similar
nature could serve as dominant positive and negative selectable
markers in mammalian cells.
Gene transfer into somatic mammalian cells as well as into
fertilized mouse embryos has become an extremely valuable
tool for study of gene structure-function relationships. Gene
transfer can be accomplished by several different methods
that include microinjection, calcium phosphate coprecipita-
tion, and electroporation. With the exception of direct mi-
croinjection of DNA into the nuclei of recipient cells, these
methods require the presence of a selectable gene in the input
DNA to permit isolation of cells that have stably incorporated
the exogenously introduced DNA. Early gene transfer ex-
periments utilized cells mutant at the thymidine kinase (tk)
locus, and a cloned herpes simplex virus (HSV) tk gene was
used as a directly selectable marker in transfecting these cells
(1). Subsequent experiments allowed introduction of nonse-
lectable DNA sequences by ligating them to the selectable tk
or by cotransfection (2). Although other selectable genes,
such as the hypoxanthine phosphoribosyltransferase (hprt),
have been introduced into appropriate mutant mammalian
cells, the need for the target cell to be mutant has limited the
types of cells that could be used as recipients. The develop-
ment of dominant selectable systems has removed this lim-
itation. The first such system used was the xanthine guano-
sine phosphoribosyltransferase gene (gpt) from Escherichia
coli (Eco-gpt; ref. 3). The gpt expression could be selected for
in hprt- or in wild-type cells. Other dominant selectable
genes have been developed, among which the neomycin
phosphotransferase (nptII or neo) is perhaps the most widely
used (4).
The ability to apply positive and negative selection systems
during the introduction ofDNA into cells has proven to be an
extremely valuable genetic tool (5). The most widely used
genes that allow positive and negative selection schemes are
hprt, tk, and adenine phosphoribosyltransferase (aprt). By
using appropriate mutants as recipients, transformed cells
that have acquired the gene can be selected positively. Cells
that have expression of these genes can subsequently be
selected in a negative manner. Unfortunately, no single gene
is available that can be selected for and against in wild-type
cells. The availability of such genes would be valuable.
To achieve this goal, we have constructed and tested fusion
genes between the bacterial neo and HSV tk genes. The neo
serves as a positive selectable marker and the tk serves as a
negative selectable marker. We here report experiments
showing that this type of bifunctional gene can be used as a
dominant positive and negative selectable marker in mam-
malian cells.
MATERIALS AND METHODS
Cells. Mouse LMTK- cells (6) were maintained in Dulbec-
co's modified Eagle's medium (DMEM, GIBCO) supple-
mented with 10% fetal calf serum (FCS). Mouse embryonic
stem (ES) cells were maintained on irradiated feeder layers of
STO cells in DMEM/10% FCS and 2% 2-mercaptoethanol.
Transfections. LMTK- cells were transfected by the cal-
cium phosphate coprecipitation method (7). For each trans-
fection, 5-7 x 105 cells were plated in 60-mm culture dishes
and incubated overnight. A calcium phosphate precipitate
with the appropriate DNA was added to each plate. No
carrier DNA was used. After 4 hr, the cells were treated for
2 min with 10% dimethyl sulfoxide in 138 mM NaCl/5 mM
KCl/0.7 mM Na2HPO4/6 mM dextrose/20 mM Hepes, pH
6.92. Mouse ES cells were transfected by electroporation
using a Bio-Rad gene pulser at 500 kF and 250 V. The
transfected cells were incubated overnight in DMEM con-
taining 10% FCS, after which they were transferred to
100-mm culture dishes and subjected to selection with G418
at 200 jig/ml (Geneticin, GIBCO) or hypoxanthine (15 jkg/
ml), aminopterin (0.2 mg/ml), and thymidine (5 tug/ml) (HAT
medium; ref. 8). Resistant colonies were counted after 14
days of selection. Individual colonies were isolated and
expanded for further analysis.
Preparation of Cell Extracts. Cell monolayers were washed
with phosphate-buffered saline, harvested, and centrifuged at
2000 x g. The cell pellet was suspended in cell lysis buffer
(0.1 M Tris, pH 6.8/0.5% Triton X-100/1 mM phenylmeth-
ylsulfonyl fluoride) at 108 cells per ml. Cells were sonicated
three times, 10 sec each time, and cell lysis was monitored by
phase-contrast microscopy. Lysed cells were centrifuged for
2 min to sediment cell membranes, nuclei, and cell debris,
and the supernatant was removed for protein analysis. Pro-
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tein concentration was estimated by the Bio-Rad protein
assay.
Gel Electrophoresis and Western Blot Analysis. Duplicates
of each sample were analyzed by SDS/polyacrylamide gel
electrophoresis, using 80-100 pug of total protein per lane
according to the procedure of Laemmli (9). Electrophoretic
transfer of proteins and antibody binding were carried out by
a modification of the protocol of Towbin et al. (10). Proteins
were transferred to nitrocellulose filter paper overnight at 200
mA in 25 mM Tris, pH 8.1/192 mM glycine made in 20%
(vol/vol) methanol. After transfer, the nitrocellulose filter
was cut in half and soaked in a solution of 3% bovine serum
albumin (fraction V, Sigma) in saline (0.9% NaCl/10 mM
Tris-HCl, pH 7.4) for 1 hr at room temperature. One half of
the nitrocellulose filter was incubated with goat antiserum
prepared against the TK protein ofthe HSV type I (a gift from
T. Silhavy, Princeton University, Princeton, NJ). The sec-
ondary antibody was rabbit anti-goat IgG (a gift from W.
Carey Hanly, University of Illinois, Chicago) diluted 1:1000
in the above buffer. The second half of the nitrocellulose filter
was incubated with primary rabbit antiserum prepared
against bacterial neo (anti-NEO antibody; a gift from L.
Shapiro, Stanford University, Palo Alto, CA). After each
incubation, filters were extensively washed in a solution of
0.05% Tween 20 prepared in Tris-buffered saline. Immuno-
reaction was visualized using goat anti-rabbit immunoglob-
ulins coupled to horseradish peroxidase (Bio-Rad) and stain-
ing with horseradish peroxidase color development reagent
according to manufacturer's specifications. The developed
membrane shows purple bands against a white background.
The sensitivity of detection by this procedure is 100 pg for a
selected purified protein.
Extraction of RNA and Northern Blot Analysis. Total cel-
lular RNA was isolated by the method of Soeiro and Darnell
(11). Ten-microgram samples of RNA were dissolved in 50
mM boric acid/5 mM sodium borate/10 mM sodium sulfate/
0.1 mM EDTA/50% formamide/6% formaldehyde, heated at
650C for 5 min, and fractionated on 1.2% agarose gels
containing 3% formaldehyde. The RNA was transferred to
nitrocellulose according to the method of Thomas (12) and
hybridized with nick-translated DNA probes. Hybridization
was conducted at 450C in 50% formamide/5 x SSC (lx SSC
= 0.15 M sodium chloride/15 mM sodium citrate)/50 mM
sodium phosphate, pH 6.8/5x Denhardt's solution (50x
EcoRI Bam Hi
Denhardt's = 5 g of Ficoll, 5 g of polyvinylpyrrolidone/5 g of
bovine serum albumin and H20 to 500 ml)/0.1% sodium
dodecyl sulfate (SDS)/60 Ag of denatured salmon sperm
DNA per ml. The filters were washed at 550C with 0.1 x
SSC/0.1% SDS. The filters were exposed to KodakXAR film
to generate autoradiographs.
RESULTS
Nature of the Test Plasmids. The HSV tk gene was derived
from pHSV106 (13) and the neo gene was derived from
pSV2neo (4). Using plasmid pSVO10 (4) as a vector, an initial
plasmid was made that contained the tk gene of the HSV type
I (HSV I tk) together with its own promoter and all of the
necessary 5' regulatory sequences (14); a promoterless copy
of the bacterial aminoglycoside phosphotransferase gene neo
(15) was inserted downstream of the tk gene. This initial
plasmid also contained the simian virus 40 (SV40) replication
origin and the SV40 early promoter regions in reverse ori-
entation with respect to the tk gene; its structure is illustrated
in the top line of Fig. 1. Several modifications of the initial
plasmid were made in the tk and neo genes resulting in three
different constructs designated TNT, TNSSS 31, and TN-
FUS 69. The regions corresponding to the end ofthe tk coding
sequences and beginning of the neo in the initial plasmid and
in each of these three constructs are also shown in Fig. 1. In
the TNT (tk-neo terminator) plasmid, the region correspond-
ing to last 7 amino acids of the TK protein was replaced by
a region coding for 6 new amino acids. The end of the TK
protein and the initiation codon for the NEO protein are
separated by 12 nucleotides (nt). Thus, the tk and neo genes
in this plasmid have their own translation initiation and
termination codons. In the TNFUS 69 (tk-neo fusion) plas-
mid, the region corresponding to the carboxyl-terminal 6
amino acids as well as the termination codon of the tk gene
was replaced by a small segment ofDNA coding for 3 amino
acids. This sequence was fused in frame to the neo coding
region starting from the translation initiation codon. Thus,
TNFUS 69 contains only one translation termination codon,
at the end of the tk-neo fusion gene. In the TNSSS 31 (tk-neo
stop-stepback-start) plasmid, the tk-neo junctional region
was further modified so that the last 6 amino acids of the tk
gene were replaced by a DNA segment coding for 20 new
amino acids. In addition, the junction between the coding
so Bam Hi Eco RI
SV40 polyA pasmid
1 kb
tk ACG TTT GCC CGG GAG ATG GGG GAG GCT AAC TGAthr phe ala arg glu met gly giy ala asn *
TNT ACG TTT GCC CCT GAT CAA GAG ACA GGA TGA GGA TCG TTT CGC ATG ATT GAA
thr phe ala pro asp gin glu thr gly * met !le glu
TNSSS 31 ACG TTT GCC CGA TCG TTT CGC ATG ATT GAA CAA GAT GGA
thr phe ala arg ser phe arg met !le glu gin asp gly
TTG CAC GCA GGT TCT CCG GCC GAT CGT TTC GCA TGATT GAA
leu his ala gly ser pro ala asp arg phe ala *
met ile glu
TNFUS 69
ACG TTT GCC CGA TCG TTT CGC ATG ATT GAA CAA GAT GGA TTG CAC GCA GGT
thr phe ala arg ser phe arg met ile glu gin asp gly leu his ala gly
neo ATG ATT GAA CAA GAT GGA TTG CAC GCA GGTmet ile glu gin asp gly leu his ala gly
FIG. 1. Junction region between the tk and neo genes in the TNT, TNSSS 31, and TNFUS 69 plasmids. The top line indicates the basic
structure of the three fusion plasmids (see text for details). tk, The DNA sequence of the 3' end of the tk gene and the amino acids it codes for;
neo, the 5' end of the neo gene and the amino acids it codes for. The DNA sequence and the corresponding amino acid sequences of the region
at the junction of tk and neo in the three fusion plasmids are shown. kb, Kilobase.
Genetics: Schwartz et al.
Proc. Natl. Acad. Sci. USA 88 (1991)
sequences for the tk and neo genes is such that 4 nt code for
the termination codon of the tk and for the initiation codon of
the neo. These 4 nt are ATGA; the TGA triplet in this
sequence serves as the termination codon for the tk, and the
ATG triplet serves as the initiation codon for neo. Thus, the
neo sequence is in the -1 reading frame with respect to the
tk sequence.
Fusion Genes Are Functional in Mammalian Cells. Each of
the three modified plasmids was introduced into mouse
LMTK- cells to test for the expression of tk and neo genes.
Two plasmids, pHSV106 and pSV2neo, were used as con-
trols. Half of the transfected cell population was selected in
HAT medium, and the other half was subjected to selection
with G418. Results from these experiments are shown in
Table 1. The data show that the tk gene in TNT did not
function and that the neo gene in this plasmid functioned
poorly. The carboxyl-terminal end of the TK protein is
known to be necessary for its function (16); our data suggest
that replacement of the last seven amino acids of the TK
protein produces a nonfunctional protein. Transfection of
cells with TNSSS 31 plasmid yielded HATR and G418R
colonies (Table 1), but the TNFUS 69 plasmid yielded the
highest frequencies of HATR and G418R colonies (Table 1).
Since mouse ES cells are being extensively used for gene
transfer and genetic manipulation, we tested the transfection
efficiencies ofTNFUS 69 and a modified version ofTNFUS
69 containing a polyoma enhancer, designated TNFUS 69PY
in these cells. The results are shown in Table 1. TNFUS 69
and TNFUS 69PY gene transfection efficiencies compare
favorably with those obtained with pMClneopolA (17).
For fusion genes to be useful in positive and negative
selection, cells carrying them must express TK and NEO
functions simultaneously. We ascertained this feature by
taking colonies obtained in each of the two selection systems
(HAT and G418) with each of the TNSSS 31 and TNFUS 69
plasmids and testing them for cross resistance. We observed
that cells isolated in HAT alone were capable of growing in
G418 or in HAT plus G418, and all of the cells initially
selected in G418 were capable of growth in HAT or in G418
plus HAT.
Fusion Genes Produce Fusion Transcripts. The structures of
the fusion genes inTNT and TNSSS 31 are such that although
a single transcript encoding the tk and neo should be pro-
duced, translation of the transcript leads to discrete TK and
NEO proteins. In TNFUS 69, however, the single transcript
generated by using the tk promoter is expected to yield a
single fusion polypeptide. To test these expectations, we
examined cells stably transfected withTNFUS 69 for a fusion
transcript and for a fusion protein. The fusion gene should
produce a single transcript that will hybridize to tk-specific
and neo-specific DNA probes. To detect such a transcript,
total RNA from four independent cell lines derived from the
Table 1. Efficiency of transfection with tk-neo fusion plasmids
HATR G418R
Colonies/ Colonies Colonies/ Colonies
Plasmid ,u* per Agt Ig* per ugt
pHSV106 750/10 75
TNT 0/8 0 1/8 0.125
TNSSS 31 14/4 3.5 23/4 5.75
TNFUS 69 240/28 8.57 1656/28 59.14
pSV2neo 800/10 80
pMClneopolAt 955/25 38.2
TNFUS 69* 1319/25 52.8
TNFUS 69PYt 1256/25 50.2
use of TNFUS 69 was fractionated on agarose gels and
hybridized with tk- and neo-specific DNA probes. Results of
an experiment of this type are presented in Fig. 2. Fig. 2a,
lane A, contains RNA from a cell line transfected with a
plasmid containing only the tk gene. This lane reveals a
1300-nt-long transcript that hybridizes to the tk-specific
probe. Lanes B-E contain RNA isolated from the four
independent TNFUS 69 transfectants. All of these cell lines
contain a single 3200- to 3300-nt-long transcript that hybrid-
izes to the tk probe. Results of hybridization of an identical
filter to a neo probe are shown in Fig. 2b. The neo probe does
not hybridize to the message produced by the cell line
transfected with a tk (lane A), but it does hybridize to an
1840-nt transcript in cells transfected with a plasmid contain-
ing only a neo (lane F). The neo probe also hybridizes to a
transcript in lanes B-E whose mobility is identical to that
detected with the tk probe. Since the predicted size of the
fusion transcript is 3240 nt, the observed size of 3200-3300 nt
is consistent with the size expected for the tk-neo fusion
transcript. These results thus indicate that the TNFUS 69
construct, when transfected into cells, produces a transcript
that jointly carries tk- and neo-specific RNA sequences and
is larger than either authentic tk or neo transcripts.
A TK-NEO Fusion Protein Is Made in TNFUS 69 Trans-
fectants. Since the TNFUS 69 plasmid contains only one
translational stop codon, at the end of the neo gene, it is
expected that its transcript will be translated into one TK-
NEO fusion protein. To test this prediction, proteins were
extracted from a HATR, G418R cell line obtained with the
TNFUS 69 plasmid, separated by electrophoresis through
polyacrylamide gel, and examined by Western blot analysis
using antisera directed against either the HSV I TK protein
or the NEO protein. Results of this analysis are shown in Fig.
3. Using anti-HSV I TK antiserum, a specific protein band of
-66 kDa was detected (Fig. 3, lane A). The molecular mass
of this protein corresponds to the expected size of the fusion
protein, as deduced from the nucleotide sequences of the
TNFUS 69 plasmid. Using antiserum against the NEO pro-
tein, a specific protein band of the same molecular mass was
detected (Fig. 3, lane C). A protein band of this size was not
detected with either antiserum in cell lysates from LMTK-
cells that had been transfected (Fig. 3, lanes B and D). These
results indicate that a single fusion TK-NEO protein is made
from the TNFUS 69 plasmid.
The fact that cells transfected with TNFUS 69 can be
selected efficiently in medium containing G418 is a clear
indication that this gene can be used as a dominant selectable
marker. The expression ofHSV tk can be efficiently selected
81!
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FIG. 2. Transcripts produced by TNFUS 69. Total RNA from
four independent TNFUS 69 transfectants was electrophoresed and
hybridized to tk (a) or neo (b) probes. Lanes A, RNA from a
pHSV106 transfectant; lanes B-E, RNA from TNIFUS 69 transfec-
tants; lane F, RNA from a pSV2neo transfectant.
R, Resistant.
*Total number of colonies/total amount of DNA used.
tColonies obtained/Ag of input DNA.
tTransfections into a mouse ES cell line.
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FIG. 3. Western blot analysis of the TK-NEO fusion protein.
Total proteins were extracted either from HATR, G418R cells ob-
tained after transfection with the TNFUS 69 plasmid (lanes A and C)
or from LMTK- cells that had not been transfected (lanes B and D).
Proteins were electrophoresed through polyacrylamide gel, trans-
ferred to a nitrocellulose filter, and analyzed by Western blot.
Samples in lanes A and B were incubated with antiserum prepared
against the HSV I TK protein. Samples in lanes C and D were
incubated with antiserum directed against the NEO protein. Anti-
gen-antibody complexes were visualized with the use of goat anti-
rabbit IgG coupled to horseradish peroxidase.
against by the use of acyclovir or ganciclovir (5). Our
observation that the TNFUS transfectants are efficiently
expressing the HSV tk gene product is an indication that the
fusion gene can be selected against.
DISCUSSION
In an effort to generate genetic markers whose expression
can be selected for and against in mammalian cells, we have
tested three different constructs involving fusions between
the HSV-tk and the bacterial neo genes. Of the three con-
structs tested, TNFUS 69 best fulfills the requirements for an
effective positive and negative selectable gene. In this con-
struct the fusion gene is expressed using the HSV tk promoter
and has an in-frame fusion between the tk and neo gene
sequences. We have shown that cells transfected with this
fusion gene yield G418R colonies at efficiencies that compare
favorably with those obtained by the use of pSV2neo or
pMClneopolA. The fusion gene yields a transcript of about
3200 nt that hybridizes to tk- as well as neo-specific probes.
The size of the transcript corresponds very closely to the
expected fusion transcript. We have also shown that cells
made G418R with TNFUS 69 are also expressing the HSV-tk
gene by demonstrating that the cells can survive in HAT or
in HAT plus G418. Further support for the view that the
fusion gene is functioning as a single unit comes from the
demonstration that antibodies against the authentic neo and
HSV-tk gene products recognize a polypeptide that is of the
same size expected from the fusion product.
There are several other genes whose expression can be
selected for or against. The most well known of these are
hprt, tk, and aprt. However, positive selection for these
genes can be achieved only in cells that are mutant at the
appropriate locus. On the other hand, positive selection for
bacterial genes such as Eco-gpt and nptII (neo) inserted into
mammalian expression vectors can be achieved, but no
suitable negative selection systems for these genes are avail-
able. In contrast, the tk-neo fusion we describe here can be
selected for or against in any cell type.
The use of a fusion gene for positive and negative selection
schemes has significant advantages over the use of a plasmid
that carries the two genes as separate cassettes. Transfection
with a two-cassette plasmid followed by selection for one of
the two genes does not require that the second gene be active.
Thus, the gene that is not selected can accumulate mutations
during the course of cell culture, which will lead to a high
background when negative selection is applied. The tk-neo
fusion gene that we have described here helps avoid this
shortcoming. By designing the fusion protein structure so
that the first selected activity (the dominant positive function)
is located distally to the second selectable marker (the
dominant negative function), problems due to mutations in
the negative selectable gene are much reduced. Strategies
similar to the ones described here may be useful in construct-
ing additional fusion genes such as between the hygromycin-
resistance gene and the HSV-tk gene. Several points need to
be kept in mind in constructing such fusion genes. Most
importantly, it should be noted that not all fusions will yield
bifunctional proteins. Amino-terminal fusions with the neo
gene have been studied by Reiss et al. (18). These investi-
gators constructed several plasmids in which the amino-
terminal region of the NEO protein, which was lacking the
ATG translation initiation codon, was fused to foreign DNA
sequences coding for 3-300 amino acids and looked for the
expression of the fused proteins in E. coli. They found that
all amino-terminal fusions examined conferred kanamycin
resistance to bacteria (equivalent to G418 resistance in mam-
malian cells) but that the level of this resistance varied
depending on the length of the added sequence. In general,
short fusions induced high levels of resistance, whereas
longer fusions showed only moderate to low kanamycin
resistance. Furthermore, they found that most of the longer
fusion proteins were not enzymatically active as such but had
to be converted into active products by proteolytic cleavage.
In addition, they found that not only the length but also the
particular structure of the added sequence affected the en-
zymatic activity of the NEO moiety. Similarly, a number of
different fusion constructs between polyoma middle tumor
antigen and neo coding sequences had to be tested to find a
suitable fusion gene that works in mouse cells (19). The
results of our experiments with the TNFUS 69 plasmid
indicate that amino-terminal fusions with the NEO protein
can result in biologically active molecules in mammalian
cells. In the TNFUS 69 plasmid, 480 amino acids of the TK
protein are fused to the amino terminus of the NEO protein.
Despite the length of the fusion, the resulting TK-NEO
fusion protein has both enzymatic activities.
The fusion gene TNFUS 69 can be used for several
purposes. For example, introduction of the fusion gene into
each of the human chromosomes in different isolates derived
from a normal diploid human cell line (by transfection and
subsequent generation of somatic cell hybrids) could allow
the selective retention and subsequent loss of individual
human chromosomes.
Fusion genes can also play an important role in gene
targeting by homologous recombination. Valencius and
Smithies (20) and Hasty et al. (21) have described strategies
to obtain subtle modifications in mouse genes by an in-out
homologous recombination procedure. In one case (20), the
vector contained a portion of the hprt gene able to correct a
partial deletion of the hprt in the recipient hprt- ES cells. The
vector also contained a 4-base-pair insertion. The "in" step
was used to introduce the vector sequences into the hprt
locus by gene targeting. In the second "out" step, homolo-
gous recombination (probably intrachromosomal) permitted
loss of the input vector. Since the recipient cells used were
Genetics: Schwartz et al.
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hprt-, the in step was made possible by selecting for the
expression of the hprt gene in HAT medium; the out step was
achieved by selecting for the loss of hprt expression by use
of 6-thioguanine-containing medium. The use of the hprt as
the dominant and negative selectable marker requires that the
target cells be hprt-. The fusion gene that we have described
here can be used for comparable experiments in which
wild-type cells are the targets for the modification. In the
second case (21), a similar in-and-out strategy involving a
vector that contains separate positively and negatively se-
lectable genes was utilized. The fusion gene that we describe
here could be used for similar purposes.
While this manuscript was in its final stages ofpreparation,
a report describing the use of a fusion gene between hygro-
mycin phosphotransferase and HSV tk for positive and
negative selections has been published (22).
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